Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-01-26 @ 7:43 AM
Study NCT ID:
NCT00709618
Status:
TERMINATED
Last Update Posted:
2014-07-14
First Post:
2008-07-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasms, Breast | View |